1. Emergence of Extensively Drug-Resistant Neisseria gonorrhoeae, France, 2023.
- Author
-
Caméléna F, Mérimèche M, Brousseau J, Mainardis M, Verger P, Le Risbé C, Brottet E, Thabuis A, Bébéar C, Molina JM, Lot F, Chazelle E, and Berçot B
- Subjects
- Adult, Female, Humans, Male, Azithromycin pharmacology, Azithromycin therapeutic use, Ceftriaxone pharmacology, Ceftriaxone therapeutic use, France epidemiology, Microbial Sensitivity Tests, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Drug Resistance, Multiple, Bacterial genetics, Gonorrhea drug therapy, Gonorrhea microbiology, Gonorrhea epidemiology, Neisseria gonorrhoeae drug effects, Neisseria gonorrhoeae genetics, Neisseria gonorrhoeae isolation & purification
- Abstract
Since 2022, Europe has had 4 cases of extensively drug-resistant Neisseria gonorrhoeae, sequence type 16406, that is resistant to ceftriaxone and highly resistant to azithromycin. We report 2 new cases from France in 2023 involving strains genetically related to the 4 cases from Europe as well as isolates from Cambodia.
- Published
- 2024
- Full Text
- View/download PDF